1-methyl-3-isobutylxanthine has been researched along with Apnea in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Apnea: A transient absence of spontaneous respiration.
Excerpt | Relevance | Reference |
---|---|---|
"4." | 1.30 | cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats. ( Ballanyi, K; Hoch, B; Lalley, PM; Richter, DW, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballanyi, K | 1 |
Lalley, PM | 1 |
Hoch, B | 1 |
Richter, DW | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Apnea
Article | Year |
---|---|
cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Animals, Newborn; Apnea; Cyclic AMP; GTP-Binding | 1997 |